Study S000190

Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06082063
Acronym: Steno1
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: NONE
Status: RECRUITING
Enrollment: 2000
Start: 2024-07-01
Primary completion: 2029-07-01
Lead sponsor: Steno Diabetes Center Copenhagen
Conditions: Cardiovascular Diseases; Heart Failure; Type 1 Diabetes; Kidney Failure
Interventions: DRUG:Aspirin tablet; DRUG:Semaglutide; DRUG:Sotagliflozin; DRUG:Finerenone
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

MACE + HHF [5 years]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.